FI895733A0 - Vattenloesningar av doxorubicin. - Google Patents

Vattenloesningar av doxorubicin.

Info

Publication number
FI895733A0
FI895733A0 FI895733A FI895733A FI895733A0 FI 895733 A0 FI895733 A0 FI 895733A0 FI 895733 A FI895733 A FI 895733A FI 895733 A FI895733 A FI 895733A FI 895733 A0 FI895733 A0 FI 895733A0
Authority
FI
Finland
Prior art keywords
doxorubicin
lubricating valve
physiologically acceptable
double
double lubricating
Prior art date
Application number
FI895733A
Other languages
English (en)
Finnish (fi)
Inventor
Murray A Kaplan
Robert K Perrone
Joseph B Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI895733A0 publication Critical patent/FI895733A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
FI895733A 1988-12-05 1989-11-30 Vattenloesningar av doxorubicin. FI895733A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27962788A 1988-12-05 1988-12-05

Publications (1)

Publication Number Publication Date
FI895733A0 true FI895733A0 (fi) 1989-11-30

Family

ID=23069771

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895733A FI895733A0 (fi) 1988-12-05 1989-11-30 Vattenloesningar av doxorubicin.

Country Status (20)

Country Link
EP (1) EP0372888B1 (hu)
JP (1) JPH02200637A (hu)
KR (1) KR920001460B1 (hu)
AT (1) ATE78402T1 (hu)
AU (1) AU612916B2 (hu)
DD (1) DD295990A5 (hu)
DE (1) DE68902223T2 (hu)
DK (1) DK609889A (hu)
ES (1) ES2044148T3 (hu)
FI (1) FI895733A0 (hu)
GR (1) GR3005391T3 (hu)
HU (1) HU204704B (hu)
IE (1) IE893867L (hu)
IL (1) IL92541A0 (hu)
NO (1) NO894811L (hu)
NZ (1) NZ231602A (hu)
OA (1) OA09898A (hu)
PT (1) PT92483B (hu)
YU (1) YU226189A (hu)
ZA (1) ZA899248B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
EP3417864A4 (en) * 2016-02-16 2019-08-21 General Incorporated Association Pharma Valley Project Supporting Organisation IMMUNOSUPPRESSION TENDERING AGENT AND USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.

Also Published As

Publication number Publication date
ES2044148T3 (es) 1994-01-01
DE68902223T2 (de) 1993-01-14
DD295990A5 (de) 1991-11-21
DK609889A (da) 1990-06-06
IE893867L (en) 1990-06-05
AU4591589A (en) 1990-06-07
KR900009081A (ko) 1990-07-02
IL92541A0 (en) 1990-08-31
NO894811L (no) 1990-06-06
EP0372888A1 (en) 1990-06-13
YU226189A (en) 1991-02-28
HUT52961A (en) 1990-09-28
PT92483B (pt) 1995-08-09
DE68902223D1 (de) 1992-08-27
JPH02200637A (ja) 1990-08-08
ZA899248B (en) 1990-08-29
HU896426D0 (en) 1990-02-28
NZ231602A (en) 1991-12-23
ATE78402T1 (de) 1992-08-15
DK609889D0 (da) 1989-12-04
HU204704B (en) 1992-02-28
AU612916B2 (en) 1991-07-18
GR3005391T3 (hu) 1993-05-24
KR920001460B1 (ko) 1992-02-14
EP0372888B1 (en) 1992-07-22
OA09898A (fr) 1994-09-15
NO894811D0 (no) 1989-12-01
PT92483A (pt) 1990-06-29

Similar Documents

Publication Publication Date Title
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
SE8402551L (sv) Cinnamoylmoranolin-derivat
FI852995A0 (fi) Stabila salter av polyanioner innehaollande s-adenosyl-l-methionin (sam).
AU564166B2 (en) Protracted release microbiocidal articles
FI854167L (fi) Mun- och tandvaordsmedel.
AU653371B2 (en) Pharmaceutical compositions
ES2033379T3 (es) Soluciones acuosas de clorhidrato de doxorubicina.
FI895733A0 (fi) Vattenloesningar av doxorubicin.
JPS5639013A (en) Ophthalmic solution for regulating intraocular tension
NZ219284A (en) Fluoboric acid salt of n-tridecyl-2,6-dimethylmorpholine and pesticidal compositions
ATE87210T1 (de) Doxorubicin-loesungen.
KR890003367A (ko) 심장질환 치료용 조성물
DK214884A (da) Chlorphenoxyacetatderivat
JPS57212117A (en) Intracranial pressure lowering agent

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY